VYNE logo

VYNE Therapeutics (VYNE) Net Income

Annual Net Income

-$28.45 M
-$5.24 M-22.59%

December 31, 2023

Summary

Performance

1-Year Change

-22.59%

3-Year Change

+88.87%

5-Year Change

+44.69%

15-Year Change

+2.15%

VYNE Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

50.8%
VYNE annual net profit is higher than 50.8% of companies in Healthcare sector

High & Low

All-time High

-$4.61 M

3-Year Low

-$73.33 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
VYNE previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
VYNE next annual earnings announcement is scheduled for Feb 28, 2025

OtherVYNEprofitabilitymetrics:

Annual Net Margin

-6710.38%
VYNE annual net profit margin is -6710.38%

Annual Revenue

$424.00 K
VYNE annual revenue is $424.00 thousand

Annual Gross Profit

-
VYNE annual gross profit value is unknown

Annual EPS

-$2.78
VYNE annual earnings per share is -$2.78

Quarterly Net Income

-$12.16 M
-$2.75 M-29.25%

September 30, 2024

Summary

Performance

3-Month Change

-29.25%

1-Year Change

-29.25%

3-Year Change

-22.24%

5-Year Change

-22.24%

VYNE Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37%
VYNE quarterly net profit is higher than 37% of companies in Healthcare sector

High & Low

All-time High

$4.67 M
VYNE quarterly net profit is currently -360.32% below its historical high of $4.67 million

3-Year Low

-$12.16 M
VYNE quarterly net profit is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VYNE previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
VYNE next earnings announcement is scheduled for Feb 28, 2025

OtherVYNEprofitabilitymetrics:

Quarterly Net Margin

-10.05 K%
VYNE quarterly net profit margin is -10.05 thousand%

Quarterly Revenue

$121.00 K
VYNE quarterly revenue is $121.00 thousand

Quarterly Gross Profit

-
VYNE quarterly gross profit value is unknown

Quarterly EPS

-$0.29
VYNE quarterly earnings per share is -$0.29

TTM Net Income

-$34.00 M
-$5.57 M-19.60%

September 30, 2024

Summary

Performance

3-Month Change

-19.6%

1-Year Change

-19.6%

3-Year Change

-46.49%

5-Year Change

-46.49%

VYNE TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.55%
VYNE TTM net profit is higher than 45.55% of companies in Healthcare sector

High & Low

All-time High

-$4.84 M

3-Year Low

-$73.33 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VYNE previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
VYNE next earnings announcement is scheduled for Feb 28, 2025

OtherVYNEprofitabilitymetrics:

Annual Net Margin

-6710.38%
VYNE annual net profit margin is -6710.38%

TTM Revenue

$493.00 K
VYNE TTM revenue is $493.00 thousand

TTM Gross Profit

-
VYNE TTM gross profit value is unknown

TTM EPS

-$1.10
VYNE TTM earnings per share is -$1.10

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$28.45 M
VYNE annual net profit is -$28.45 million

Annual Revenue

$424.00 K
VYNE annual revenue is $424.00 thousand

Annual Cost Of Goods Sold

-
VYNE annual cost of goods sold value is unknown

Annual Operating Expenses

$29.68 M
VYNE annual total operating expenses is $29.68 million

Annual Interest Expense

-
VYNE annual interest expense value is unknown

Annual Income Tax

$0.00
VYNE annual income tax is $0.00

VYNE Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-22.6%-29.3%-19.6%
3 y3 years+88.9%-22.2%-46.5%
5 y5 years+44.7%-22.2%-46.5%

VYNE Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-22.6%+61.2%-360.3%at low-46.5%+53.6%
5 y5-year-22.6%+88.9%-360.3%+92.7%-46.5%+86.7%
alltimeall time-517.5%+88.9%-360.3%+92.7%-602.9%+86.7%

VYNE Therapeutics Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$12.16 M(+29.2%)
-$34.00 M(+19.6%)
Jun 2024
-
-$9.41 M(+50.5%)
-$28.43 M(-2.2%)
Mar 2024
-
-$6.25 M(+1.0%)
-$29.08 M(+2.2%)
Dec 2023
-$28.45 M(+22.6%)
-$6.19 M(-6.0%)
-$28.45 M(-11.7%)
Sep 2023
-
-$6.58 M(-34.5%)
-$32.21 M(-8.2%)
Jun 2023
-
-$10.06 M(+78.9%)
-$35.08 M(+4.7%)
Mar 2023
-
-$5.62 M(-43.5%)
-$33.50 M(+44.3%)
Dec 2022
-$23.21 M(-68.3%)
-$9.95 M(+5.1%)
-$23.21 M(-6.5%)
Sep 2022
-
-$9.46 M(+11.6%)
-$24.84 M(-32.3%)
Jun 2022
-
-$8.48 M(-281.5%)
-$36.66 M(-23.8%)
Mar 2022
-
$4.67 M(-140.4%)
-$48.11 M(-34.4%)
Dec 2021
-$73.33 M(-71.3%)
-$11.57 M(-45.6%)
-$73.33 M(-13.7%)
Sep 2021
-
-$21.29 M(+6.8%)
-$84.94 M(-3.9%)
Jun 2021
-
-$19.92 M(-3.0%)
-$88.37 M(-62.5%)
Mar 2021
-
-$20.55 M(-11.3%)
-$235.88 M(-7.7%)
Dec 2020
-$255.57 M
-$23.18 M(-6.2%)
-$255.57 M(+0.7%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$24.71 M(-85.2%)
-$253.88 M(+3.2%)
Jun 2020
-
-$167.44 M(+316.2%)
-$246.03 M(+158.8%)
Mar 2020
-
-$40.23 M(+87.1%)
-$95.06 M(+29.0%)
Dec 2019
-$73.70 M(+43.3%)
-$21.50 M(+27.5%)
-$73.70 M(+5.6%)
Sep 2019
-
-$16.86 M(+2.3%)
-$69.80 M(+6.1%)
Jun 2019
-
-$16.48 M(-12.7%)
-$65.79 M(+14.1%)
Mar 2019
-
-$18.87 M(+7.3%)
-$57.66 M(+12.1%)
Dec 2018
-$51.45 M(+76.9%)
-$17.59 M(+36.9%)
-$51.44 M(+19.3%)
Sep 2018
-
-$12.85 M(+53.9%)
-$43.13 M(+12.2%)
Jun 2018
-
-$8.35 M(-34.1%)
-$38.45 M(+6.1%)
Mar 2018
-
-$12.66 M(+36.4%)
-$36.26 M(+24.7%)
Dec 2017
-$29.08 M(+106.7%)
-$9.28 M(+13.5%)
-$29.07 M(+18.0%)
Sep 2017
-
-$8.17 M(+32.8%)
-$24.64 M(+49.6%)
Jun 2017
-
-$6.15 M(+12.4%)
-$16.46 M(+59.7%)
Mar 2017
-
-$5.47 M(+13.2%)
-$10.31 M(+113.2%)
Dec 2016
-$14.07 M(+205.3%)
-$4.84 M
-$4.84 M
Dec 2015
-$4.61 M
-
-

FAQ

  • What is VYNE Therapeutics annual net profit?
  • What is the all time high annual net income for VYNE Therapeutics?
  • What is VYNE Therapeutics annual net income year-on-year change?
  • What is VYNE Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for VYNE Therapeutics?
  • What is VYNE Therapeutics quarterly net income year-on-year change?
  • What is VYNE Therapeutics TTM net profit?
  • What is the all time high TTM net income for VYNE Therapeutics?
  • What is VYNE Therapeutics TTM net income year-on-year change?

What is VYNE Therapeutics annual net profit?

The current annual net income of VYNE is -$28.45 M

What is the all time high annual net income for VYNE Therapeutics?

VYNE Therapeutics all-time high annual net profit is -$4.61 M

What is VYNE Therapeutics annual net income year-on-year change?

Over the past year, VYNE annual net profit has changed by -$5.24 M (-22.59%)

What is VYNE Therapeutics quarterly net profit?

The current quarterly net income of VYNE is -$12.16 M

What is the all time high quarterly net income for VYNE Therapeutics?

VYNE Therapeutics all-time high quarterly net profit is $4.67 M

What is VYNE Therapeutics quarterly net income year-on-year change?

Over the past year, VYNE quarterly net profit has changed by -$2.75 M (-29.25%)

What is VYNE Therapeutics TTM net profit?

The current TTM net income of VYNE is -$34.00 M

What is the all time high TTM net income for VYNE Therapeutics?

VYNE Therapeutics all-time high TTM net profit is -$4.84 M

What is VYNE Therapeutics TTM net income year-on-year change?

Over the past year, VYNE TTM net profit has changed by -$5.57 M (-19.60%)